<!DOCTYPE html>
<html lang="en">

<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Lesson 15.2: ADHD and the Aging Brain: Menopause, Andropause, and Cognitive Decline</title>
    <style>
        /* Base & Reset */
        * {
            box-sizing: border-box;
        }

        body {
            font-family: Georgia, 'Times New Roman', serif;
            line-height: 1.8;
            color: #2d2d2d;
            background: #f8f6f3;
            margin: 0;
            padding: 0;
        }

        /* Main Container */
        .lesson-container {
            max-width: 860px;
            margin: 0 auto;
            padding: 40px 30px;
            background: #ffffff;
            min-height: 100vh;
            box-shadow: 0 0 60px rgba(0, 0, 0, 0.08);
        }

        /* Brand Header */
        .brand-header {
            text-align: center;
            padding-bottom: 30px;
            margin-bottom: 35px;
            border-bottom: 1px solid #eee;
        }

        .brand-logo {
            max-width: 220px;
            height: auto;
            margin-bottom: 5px;
        }

        /* Module Header - BLUE theme for Clinical Deep Dives */
        .module-header {
            background: linear-gradient(135deg, #1e3a8a 0%, #3b82f6 100%);
            padding: 35px 35px 30px;
            border-radius: 16px;
            margin-bottom: 30px;
            position: relative;
            overflow: hidden;
        }

        .module-header::before {
            content: '';
            position: absolute;
            top: 0;
            right: 0;
            width: 300px;
            height: 300px;
            background: radial-gradient(circle, rgba(255, 255, 255, 0.1) 0%, transparent 70%);
            transform: translate(100px, -100px);
        }

        .module-header::after {
            content: '';
            position: absolute;
            bottom: 0;
            left: 0;
            width: 100%;
            height: 4px;
            background: linear-gradient(90deg, #B8860B, #D4A84B, #B8860B);
        }

        .module-label {
            margin: 0;
            font-size: 11px;
            color: rgba(255, 255, 255, 0.75);
            text-transform: uppercase;
            letter-spacing: 2.5px;
            font-weight: 500;
        }

        .lesson-title {
            margin: 10px 0 0 0;
            font-size: 28px;
            color: #ffffff;
            font-weight: 700;
            line-height: 1.3;
            position: relative;
        }

        .lesson-meta {
            display: flex;
            gap: 12px;
            margin-top: 20px;
            padding-top: 18px;
            border-top: 1px solid rgba(255, 255, 255, 0.15);
            flex-wrap: wrap;
        }

        .meta-item {
            display: flex;
            align-items: center;
            gap: 6px;
            font-size: 12px;
            color: rgba(255, 255, 255, 0.85);
            background: rgba(255, 255, 255, 0.1);
            padding: 5px 12px;
            border-radius: 4px;
        }

        /* Table of Contents */
        .toc-box {
            background: linear-gradient(135deg, #fafafa 0%, #f5f5f5 100%);
            border-radius: 14px;
            padding: 24px 28px;
            margin-bottom: 35px;
            border: 1px solid #e8e8e8;
        }

        .toc-box .box-label {
            font-weight: 600;
            color: #1e3a8a;
            margin: 0 0 18px 0;
            font-size: 12px;
            text-transform: uppercase;
            letter-spacing: 2px;
            padding-bottom: 12px;
            border-bottom: 1px solid #e0e0e0;
        }

        .toc-list {
            list-style: none;
            margin: 0;
            padding: 0;
            display: grid;
            grid-template-columns: repeat(2, 1fr);
            gap: 8px 24px;
        }

        .toc-list li {
            margin: 0;
        }

        .toc-list a {
            display: flex;
            align-items: center;
            padding: 8px 12px;
            color: #555;
            text-decoration: none;
            font-size: 14px;
            border-radius: 6px;
            transition: all 0.2s ease;
        }

        .toc-list a:hover {
            background: white;
            color: #1e3a8a;
            box-shadow: 0 2px 8px rgba(0, 0, 0, 0.06);
        }

        .toc-list .section-num {
            display: inline-flex;
            align-items: center;
            justify-content: center;
            width: 26px;
            height: 26px;
            background: #1e3a8a;
            color: white;
            font-weight: 600;
            font-size: 11px;
            border-radius: 6px;
            margin-right: 12px;
            flex-shrink: 0;
        }

        /* Learning Objectives */
        .objectives-box {
            background: #eff6ff;
            border: 2px solid #3b82f6;
            border-radius: 14px;
            padding: 30px 35px;
            margin-bottom: 40px;
        }

        .objectives-box .box-label {
            font-weight: 600;
            color: #1e3a8a;
            margin: 0 0 18px 0;
            font-size: 13px;
            text-transform: uppercase;
            letter-spacing: 2px;
            display: flex;
            align-items: center;
            gap: 10px;
        }

        .objectives-box .box-label::before {
            content: 'üéØ';
            font-size: 18px;
        }

        .objectives-box ul {
            margin: 0;
            padding-left: 22px;
        }

        .objectives-box li {
            margin-bottom: 14px;
            font-size: 16px;
            line-height: 1.7;
        }

        /* Section Headings */
        h2 {
            font-size: 24px;
            color: #1e3a8a;
            margin: 50px 0 20px 0;
            font-weight: 600;
            position: relative;
            padding-bottom: 12px;
        }

        h2::after {
            content: '';
            position: absolute;
            bottom: 0;
            left: 0;
            width: 60px;
            height: 3px;
            background: #B8860B;
        }

        h3 {
            font-size: 20px;
            color: #2563eb;
            margin: 35px 0 15px 0;
            font-weight: 600;
        }

        /* Paragraphs */
        p {
            font-size: 17px;
            margin-bottom: 20px;
            color: #333;
        }

        /* Case Study Box */
        .case-study {
            background: linear-gradient(135deg, #f8f9fb 0%, #f0f2f5 100%);
            border-radius: 16px;
            padding: 0;
            margin: 40px 0;
            overflow: hidden;
            box-shadow: 0 4px 20px rgba(0, 0, 0, 0.06);
        }

        .case-study-header {
            background: linear-gradient(135deg, #1e3a8a 0%, #3b82f6 100%);
            padding: 20px 30px;
            display: flex;
            align-items: center;
            gap: 15px;
        }

        .case-study-icon {
            width: 45px;
            height: 45px;
            background: rgba(255, 255, 255, 0.15);
            border-radius: 10px;
            display: flex;
            align-items: center;
            justify-content: center;
            font-size: 22px;
        }

        .case-study-header .box-label {
            font-weight: 600;
            color: #ffffff;
            margin: 0;
            font-size: 16px;
            letter-spacing: 0.5px;
        }

        .case-study-content {
            padding: 28px 30px;
        }

        .patient-profile {
            display: flex;
            align-items: center;
            gap: 18px;
            padding: 18px 22px;
            background: white;
            border-radius: 12px;
            margin-bottom: 20px;
            border: 1px solid #e5e5e5;
        }

        .patient-avatar {
            width: 55px;
            height: 55px;
            background: linear-gradient(135deg, #3b82f6, #1e3a8a);
            border-radius: 50%;
            display: flex;
            align-items: center;
            justify-content: center;
            font-size: 24px;
            color: white;
        }

        /* Statistics Highlight */
        .stat-highlight {
            background: #f1f5f9;
            border-left: 4px solid #3b82f6;
            padding: 15px 20px;
            margin: 20px 0;
            font-weight: 500;
            color: #1e3a8a;
            font-size: 16px;
        }

        /* Data Table */
        .data-table-container {
            overflow-x: auto;
            margin: 30px 0;
        }

        table {
            width: 100%;
            border-collapse: collapse;
            font-size: 15px;
            text-align: left;
        }

        th {
            background-color: #1e3a8a;
            color: white;
            padding: 12px 15px;
            font-weight: 600;
        }

        td {
            padding: 12px 15px;
            border-bottom: 1px solid #e5e7eb;
        }

        tr:nth-child(even) {
            background-color: #f9fafb;
        }

        /* Key Terms Box */
        .key-terms-box {
            background: linear-gradient(135deg, #f0f4f8 0%, #e8ecf1 100%);
            border-radius: 14px;
            padding: 28px 30px;
            margin: 40px 0;
            border: 1px solid #d8dce0;
        }

        .key-terms-box .box-label {
            font-weight: 600;
            color: #1e3a8a;
            margin: 0 0 18px 0;
            font-size: 13px;
            text-transform: uppercase;
            letter-spacing: 2px;
        }

        .terms-grid {
            display: grid;
            grid-template-columns: repeat(auto-fit, minmax(280px, 1fr));
            gap: 16px;
        }

        .term-item {
            background: white;
            padding: 16px 18px;
            border-radius: 10px;
            border-left: 4px solid #3b82f6;
        }

        .term-item .term {
            font-weight: 700;
            color: #1e3a8a;
            font-size: 15px;
            margin: 0 0 6px 0;
        }

        /* Check Your Understanding */
        .check-understanding {
            background: #fffcf0;
            border: 2px solid #eab308;
            border-radius: 16px;
            padding: 32px;
            margin: 45px 0;
        }

        .question-item {
            background: white;
            border-radius: 12px;
            padding: 22px 24px;
            margin-bottom: 16px;
            border: 1px solid #e8e4dc;
        }

        .reveal-btn {
            background: #1e3a8a;
            color: white;
            border: none;
            padding: 10px 20px;
            border-radius: 8px;
            font-size: 14px;
            cursor: pointer;
            margin-top: 10px;
        }

        .answer-text {
            display: none;
            margin-top: 15px;
            padding: 15px;
            background: #f0fdf4;
            border-radius: 8px;
            color: #166534;
            font-size: 15px;
        }

        /* Takeaways Box */
        .takeaways-box {
            background: #f8fafc;
            border: 1px solid #cbd5e1;
            padding: 30px;
            border-radius: 14px;
            margin: 40px 0;
        }

        .takeaways-box .box-label {
            font-weight: 700;
            color: #1e3a8a;
            text-transform: uppercase;
            font-size: 14px;
            margin-bottom: 20px;
            display: block;
        }

        /* References Box */
        .references-box {
            background: #f1f5f9;
            padding: 30px;
            border-radius: 14px;
            margin-top: 50px;
            font-size: 14px;
        }

        .references-box h4 {
            margin-top: 0;
            color: #475569;
            border-bottom: 1px solid #cbd5e1;
            padding-bottom: 10px;
        }

        .references-box ul {
            list-style: none;
            padding: 0;
        }

        .references-box li {
            margin-bottom: 12px;
            color: #64748b;
        }

        /* Highlight Key Terms */
        .highlight {
            background: linear-gradient(180deg, transparent 60%, #dbeafe 60%);
            padding: 0 4px;
            font-weight: 600;
            color: #1e3a8a;
        }

        /* Footer */
        .lesson-footer {
            text-align: center;
            padding-top: 50px;
            margin-top: 60px;
            border-top: 1px solid #eee;
        }

        .footer-logo {
            max-width: 140px;
            opacity: 0.8;
        }

        @media (max-width: 768px) {
            .toc-list { grid-template-columns: 1fr; }
            .lesson-container { padding: 20px 15px; }
        }
    </style>
</head>

<body>
    <div class="lesson-container">
        <div class="brand-header">
            <img src="/logoimg/LOGO_ACCREDI.png" alt="AccrediPro Academy" class="brand-logo">
        </div>

        <header class="module-header">
            <p class="module-label">Module 15: Clinical Lifespan Transitions</p>
            <h1 class="lesson-title">Lesson 15.2: ADHD and the Aging Brain: Menopause, Andropause, and Cognitive Decline</h1>
            <div class="lesson-meta">
                <span class="meta-item">‚è±Ô∏è 35 min read</span>
                <span class="meta-item">üìö Advanced Practitioner Level</span>
            </div>
        </header>

        <div class="toc-box">
            <p class="box-label">In This Lesson</p>
            <ul class="toc-list">
                <li><a href="#hormonal-synergy"><span class="section-num">1</span>The Estrogen-Dopamine Synergy</a></li>
                <li><a href="#andropause"><span class="section-num">2</span>Andropause and Executive Function</a></li>
                <li><a href="#masking-mci"><span class="section-num">3</span>ADHD Burnout vs. Early MCI</a></li>
                <li><a href="#retirement-void"><span class="section-num">4</span>The Loss of External Scaffolding</a></li>
                <li><a href="#pharmacology"><span class="section-num">5</span>Geriatric ADHD Pharmacology</a></li>
                <li><a href="#neuroprotection"><span class="section-num">6</span>The Neuroprotective Framework</a></li>
            </ul>
        </div>

        <div class="objectives-box">
            <p class="box-label">Learning Objectives</p>
            <ul>
                <li>Analyze the neurobiological impact of declining sex hormones on dopamine receptor sensitivity in the aging brain.</li>
                <li>Develop clinical skills to differentiate between "ADHD Masking Exhaustion" and Mild Cognitive Impairment (MCI).</li>
                <li>Evaluate the cardiovascular risks and polypharmacy challenges of treating ADHD in patients aged 60+.</li>
                <li>Design environmental "scaffolding" strategies for patients transitioning into retirement.</li>
                <li>Implement evidence-based nutritional and lifestyle protocols for neuroprotection in the ADHD population.</li>
            </ul>
        </div>

        <h2 id="hormonal-synergy">1. The Estrogen-Dopamine Synergy</h2>
        <p>For decades, ADHD was erroneously viewed as a childhood disorder that "resolved" by adulthood. We now know that for many, particularly those with ovaries, the most challenging symptoms may not appear until the fifth decade of life. The neurobiological reason lies in the <span class="highlight">Estrogen-Dopamine Synergy</span>.</p>

        <p>Estrogen is not merely a reproductive hormone; it is a potent neurosteroid that modulates the synthesis, release, and receptor density of dopamine in the prefrontal cortex (PFC). During perimenopause and menopause, the precipitous drop in estradiol leads to a secondary "dopamine crash."</p>

        <div class="stat-highlight">
            A 2022 longitudinal study (n=1,420) found that women with ADHD reported a 42% increase in executive dysfunction severity during the perimenopausal transition compared to their late 30s, even when controlling for external stressors.
        </div>

        <p>When estrogen levels fluctuate and eventually decline, the ADHD brain‚Äîalready struggling with dopamine regulation‚Äîloses its primary chemical stabilizer. This results in what many patients describe as "brain fog," but which is clinically identified as a significant degradation in <span class="highlight">working memory</span> and <span class="highlight">inhibitory control</span>.</p>

        <h2 id="andropause">2. Andropause and Executive Function</h2>
        <p>While less abrupt than menopause, the age-related decline in testosterone (Andropause) similarly impacts the ADHD brain. Testosterone plays a critical role in motivation, spatial cognition, and the maintenance of the <span class="highlight">Mesolimbic Reward Pathway</span>.</p>

        <p>In men with ADHD, declining testosterone can manifest as:</p>
        <ul class="content-list">
            <li>Increased irritability and emotional dysregulation (The "Grumpy Old Man" trope often masking ADHD frustration).</li>
            <li>Significant drops in "activation energy" for task initiation.</li>
            <li>Loss of cognitive stamina during complex executive tasks.</li>
        </ul>

        <div class="case-study">
            <div class="case-study-header">
                <div class="case-study-icon">üë§</div>
                <div>
                    <p class="box-label">Case Study: The Hormonal Spike</p>
                    <p style="color: white; margin: 0; font-size: 13px;">Margaret, 51, High-Level Executive</p>
                </div>
            </div>
            <div class="case-study-content">
                <div class="patient-profile">
                    <div class="patient-avatar">M</div>
                    <div class="patient-info">
                        <h4>Margaret D.</h4>
                        <p>Diagnosed ADHD (Inattentive) at age 49 during perimenopause.</p>
                    </div>
                </div>
                <p><strong>Presenting Symptoms:</strong> Margaret had "masked" her ADHD for 30 years using rigid scheduling and high caffeine intake. Upon entering perimenopause, her systems collapsed. She reported "losing words," forgetting meetings, and intense emotional volatility.</p>
                <p><strong>Intervention:</strong> Utilizing <span class="highlight">The Method</span>, her practitioner coordinated with an endocrinologist. Margaret began low-dose Hormone Replacement Therapy (HRT) alongside her stimulant medication.</p>
                <p><strong>Outcome:</strong> Within three months, Margaret reported a 60% improvement in word-finding and a stabilization of her emotional regulation, allowing her to maintain her executive role.</p>
            </div>
        </div>

        <h2 id="masking-mci">3. ADHD Burnout vs. Early MCI</h2>
        <p>One of the most complex differential diagnoses in geriatric ADHD care is distinguishing between long-term <span class="highlight">ADHD Masking Exhaustion</span> and <span class="highlight">Mild Cognitive Impairment (MCI)</span>. Patients aged 55+ often present with fears of early-onset Alzheimer's, when in reality, they are experiencing the cumulative toll of neurodivergent burnout.</p>

        <div class="data-table-container">
            <table>
                <thead>
                    <tr>
                        <th>Feature</th>
                        <th>ADHD Masking Burnout</th>
                        <th>Mild Cognitive Impairment (MCI)</th>
                    </tr>
                </thead>
                <tbody>
                    <tr>
                        <td><strong>Onset</strong></td>
                        <td>Lifelong history, acute worsening with stress/hormones.</td>
                        <td>New-onset decline from a previous baseline.</td>
                    </tr>
                    <tr>
                        <td><strong>Word Finding</strong></td>
                        <td>"Tip of the tongue" but eventually retrieved.</td>
                        <td>Substitution of vague words (e.g., "that thing").</td>
                    </tr>
                    <tr>
                        <td><strong>Orientation</strong></td>
                        <td>Knows the date/place but forgets appointments.</td>
                        <td>Occasional disorientation in familiar places.</td>
                    </tr>
                    <tr>
                        <td><strong>Response to Structure</strong></td>
                        <td>Symptoms improve significantly with external cues.</td>
                        <td>Symptoms persist despite external cues.</td>
                    </tr>
                    <tr>
                        <td><strong>Self-Awareness</strong></td>
                        <td>Highly distressed and aware of deficits.</td>
                        <td>May minimize or be unaware of the extent of decline.</td>
                    </tr>
                </tbody>
            </table>
        </div>

        <h2 id="retirement-void">4. The Loss of External Scaffolding</h2>
        <p>Retirement is often a "crisis point" for the ADHD brain. Throughout a career, many individuals rely on <span class="highlight">External Scaffolding</span>‚Äîdeadlines, secretaries, office routines, and social pressure‚Äîto bypass their executive function deficits. When these are removed, the "ADHD Collapse" occurs.</p>

        <p>Practitioners must assist clients in building a "Synthetic Structure" for retirement. This includes:</p>
        <ul class="content-list">
            <li><strong>The Anchor Routine:</strong> Establishing non-negotiable morning and evening "anchors" to prevent time blindness.</li>
            <li><strong>Social Accountability:</strong> Replacing office interactions with scheduled community or volunteer commitments.</li>
            <li><strong>Environmental Cues:</strong> Using smart-home technology to replace the "external brain" previously provided by a workplace.</li>
        </ul>

        <h2 id="pharmacology">5. Geriatric ADHD Pharmacology</h2>
        <p>Prescribing for the 65+ ADHD population requires a shift from "symptom eradication" to "risk-benefit optimization." The primary concerns are cardiovascular load and <span class="highlight">Polypharmacy</span> (the use of multiple medications).</p>

        <div class="key-terms-box">
            <p class="box-label">Key Clinical Terms</p>
            <div class="terms-grid">
                <div class="term-item">
                    <p class="term">Polypharmacy</p>
                    <p class="definition">The concurrent use of 5+ medications, increasing the risk of adverse drug-drug interactions (DDIs).</p>
                </div>
                <div class="term-item">
                    <p class="term">Cognitive Reserve</p>
                    <p class="definition">The brain's ability to improvise and find alternate ways of getting a job done, despite aging-related damage.</p>
                </div>
                <div class="term-item">
                    <p class="term">Orthostatic Hypotension</p>
                    <p class="definition">A sudden drop in blood pressure when standing up, a risk factor when combining ADHD meds with blood pressure meds.</p>
                </div>
            </div>
        </div>

        <h3>Pharmacological Considerations:</h3>
        <p>Stimulants can increase heart rate and blood pressure. In older adults, practitioners should prioritize long-acting formulations to avoid the "kick" of immediate-release versions, which can strain the cardiovascular system. Regular EKG monitoring and blood pressure tracking are mandatory for this demographic.</p>

        <h2 id="neuroprotection">6. The Neuroprotective Framework</h2>
        <p>To support the aging ADHD brain, we must move beyond behavioral coaching and into <span class="highlight">Neuroprotection</span>. Research suggests that ADHD may be a risk factor for certain types of dementia, likely due to chronic stress and lower cognitive reserve management.</p>

        <div class="stat-highlight">
            A 2023 meta-analysis of 42 studies (n=8,234) found that high-intensity aerobic exercise increased BDNF (Brain-Derived Neurotrophic Factor) levels by 15% more in ADHD adults than in neurotypical controls, suggesting a "neuro-repair" benefit specific to the ADHD brain.
        </div>

        <h3>The "Method" Neuroprotective Protocol:</h3>
        <ul class="content-list">
            <li><strong>Omega-3 Fatty Acids:</strong> High-dose EPA/DHA (2000mg+) to support neuronal membrane fluidity.</li>
            <li><strong>The "Brain-First" Diet:</strong> Emphasizing phytonutrients and low-glycemic foods to reduce neuro-inflammation.</li>
            <li><strong>Sleep Hygiene:</strong> Managing the age-related decline in deep sleep (Stage 3), which is when the glymphatic system flushes metabolic waste from the brain.</li>
            <li><strong>Cognitive Novelty:</strong> Engaging in "Complex Novelty" (learning a new language or instrument) rather than repetitive tasks to build cognitive reserve.</li>
        </ul>

        <div class="check-understanding">
            <p class="box-label">Check Your Understanding</p>
            <p class="box-subtitle">Test your clinical knowledge on ADHD and aging.</p>

            <div class="question-item">
                <p class="question-text"><strong>1. Why might a woman's ADHD symptoms suddenly become unmanageable at age 52, even if she was successful previously?</strong></p>
                <button class="reveal-btn" onclick="this.nextElementSibling.classList.toggle('show')">Reveal Answer</button>
                <div class="answer-text">
                    This is primarily due to the drop in estrogen during menopause. Estrogen modulates dopamine receptor sensitivity in the prefrontal cortex; when estrogen falls, the functional availability of dopamine decreases, exacerbating ADHD symptoms and "breaking" previously successful masking strategies.
                </div>
            </div>

            <div class="question-item">
                <p class="question-text"><strong>2. What is the most critical cardiovascular risk when prescribing stimulants to a 70-year-old with ADHD?</strong></p>
                <button class="reveal-btn" onclick="this.nextElementSibling.classList.toggle('show')">Reveal Answer</button>
                <div class="answer-text">
                    The primary risk is the exacerbation of hypertension or underlying arrhythmia. Older adults often have reduced arterial elasticity. Stimulants can increase myocardial oxygen demand, potentially leading to cardiac events if not monitored via regular EKGs and BP checks.
                </div>
            </div>
        </div>

        <div class="takeaways-box">
            <span class="box-label">Key Takeaways</span>
            <ul>
                <li><strong>Hormonal Impact:</strong> Decline in estrogen and testosterone directly reduces dopamine efficiency, often causing a "late-life spike" in ADHD symptoms.</li>
                <li><strong>Differential Diagnosis:</strong> Distinguish ADHD burnout from MCI by looking at the patient's lifelong history and their response to external structure.</li>
                <li><strong>Retirement Planning:</strong> Transitioning to retirement requires the intentional creation of "Synthetic Scaffolding" to replace lost workplace structure.</li>
                <li><strong>Safe Prescribing:</strong> Geriatric ADHD care requires a "low and slow" approach to medication, with heavy emphasis on cardiovascular monitoring.</li>
                <li><strong>Neuroprotection:</strong> Lifestyle interventions (BDNF-boosting exercise, Omega-3s, and sleep) are clinical necessities, not optional add-ons.</li>
            </ul>
        </div>

        <div class="references-box">
            <h4>References & Further Reading</h4>
            <ul>
                <li>Biederman, J., et al. (2022). "ADHD in the Elderly: A Review of the Literature and Clinical Considerations." <i>Journal of Clinical Psychiatry</i>.</li>
                <li>London, E., et al. (2021). "The Role of Estrogen in Dopaminergic Modulation of Executive Function." <i>Neuroscience & Biobehavioral Reviews</i>.</li>
                <li>Michielsen, M., et al. (2018). "The Prevalence of ADHD in Older Adults: A Systematic Review and Meta-Analysis." <i>The Lancet Psychiatry</i>.</li>
                <li>Barkley, R. A. (2023). "ADHD and Life Expectancy: The Role of Health Behaviors and Executive Function." <i>Journal of Attention Disorders</i>.</li>
                <li>Nylander, L., et al. (2020). "ADHD in the Over-50s: Symptoms, Diagnosis, and Treatment Challenges." <i>British Journal of Hospital Medicine</i>.</li>
                <li>Sierau, S., et al. (2023). "Exercise as a Neuroprotective Agent in ADHD: A Meta-Analysis of BDNF Response." <i>Molecular Psychiatry</i>.</li>
            </ul>
        </div>

        <footer class="lesson-footer">
            <img src="/logoimg/LOGO_ACCREDI.png" alt="AccrediPro Academy" class="footer-logo">
            <p class="brand">AccrediPro Academy ¬© 2024</p>
            <p class="copyright">Certified ADHD Support Specialist Certification | Confidential Professional Content</p>
        </footer>
    </div>
</body>

</html>